Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways.
Wang, X; Chen, X; Zhou, W; Men, H; Bao, T; Sun, Y; Wang, Q; Tan, Y; Keller, BB; Tong, Q; et al.
Acta Pharmaceutica Sinica B.
2021.
Emerging roles of microRNA-208a in cardiology and reverse cardio-oncology.
Wang, X; Chen, X; Xu, H; Zhou, S; Zheng, Y; Keller, BB; Cai, L.
Medicinal Research Reviews.
2021;
41:2172-2194.
Better Outcomes in Pulmonary Arterial Hypertension After Repair of Congenital Heart Disease, Compared With Idiopathic Pulmonary Arterial Hypertension.
Xu, Z; Gatzoulis, MA; Dimopoulos, K; Li, Q; Zhang, C; Keller, BB; Gu, H.
CJC open.
2021;
3:872-879.
Engineered cardiac tissues: a novel in vitro model to investigate the pathophysiology of mouse diabetic cardiomyopathy.
Wang, X; Chen, XX; Yu, HT; Tan, Y; Lin, Q; Keller, BB; Zheng, Y; Cai, L.
Acta Pharmacologica Sinica.
2021;
42:932-941.
Zinc as a countermeasure for cadmium toxicity.
Yu, H; Zhen, J; Leng, J; Cai, L; Ji, H; Keller, BB.
Acta Pharmacologica Sinica.
2021;
42:340-346.
Successful outcomes for atrial septal defect associated with pulmonary arterial hypertension using a “treat-repair-treat” strategy.
He, Y; Li, Q; Zhang, C; Keller, BB; Gu, H.
International journal of cardiology congenital heart disease.
2021;
2.
Chronic Optogenetic Pacing of Human-Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissues.
Dwenger, M; Kowalski, WJ; Masumoto, H; Nakane, T; Keller, BB.
Methods in Molecular Biology.
2021;
2191:151-169.
Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.
Tan, Y; Zhang, Z; Zheng, C; Wintergerst, KA; Keller, BB; Cai, L.
Nature Reviews Cardiology.
2020;
17:585-607.
Validating the Paradigm That Biomechanical Forces Regulate Embryonic Cardiovascular Morphogenesis and Are Fundamental in the Etiology of Congenital Heart Disease.
Keller, BB; Kowalski, WJ; Tinney, JP; Tobita, K; Hu, N.
Journal of Cardiovascular Development and Disease.
2020;
7.
Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair.
Nakane, T; Abulaiti, M; Sasaki, Y; Kowalski, WJ; Keller, BB; Masumoto, H.
Journal of Visualized Experiments.
2020.